Frier Levitt achieved a series of significant victories before the Office of Medicare Hearings and Appeals (OMHA), securing five separate fully favorable Administrative Law Judge (ALJ) decisions that reversed alleged Medicare overpayments tied to advanced wound-care products and related application services. The rulings demonstrate the importance of a claim-specific appeal strategy supported by clinical evidence, accurate coding, and applicable Medicare coverage requirements when challenging post-payment audit findings involving wound-care services.
The Medicare Audit and Wound-Care Overpayment Allegations
The matters arose from a post-payment audit in which Medicare alleged overpayments against an experienced wound-care provider across multiple dates of service. The disputed claims involved an amniotic membrane skin substitute, a cellular and/or tissue-based product billed to Medicare under a Q code, together with associated application services. As is increasingly common in advanced wound-care audits, the contractor questioned coverage, medical necessity, and coding, placing substantial reimbursement at risk.
Frier Levitt developed a comprehensive appeal strategy focused on rebuilding the evidentiary record from the ground up. Rather than relying on generalized arguments, the team addressed coverage, coding, and medical necessity on a claim-by-claim basis. Clinical documentation, progress notes, and product records were carefully aligned with Medicare policy to demonstrate that each service met the applicable “reasonable and necessary” standard.
The Administrative Law Judge Hearings
At the ALJ level, Frier Levitt presented a clear, patient-centered narrative and rebutted the allegations originally raised by the Unified Program Integrity Contractor (UPIC) auditors, which had been carried forward through the Medicare Administrative Contractor (MAC) and Qualified Independent Contractor (QIC) appeal levels.
The treating physician testified in detail about the medical necessity of each disputed date of service, explaining the clinical decision-making that drove the use of the wound-care product and related services, including the patients’ comorbidities, the failure of more than thirty days of conservative treatment, and the persistence of non-healing wounds despite documented conservative measures. A coding expert then translated complex billing and documentation issues into plain terms, addressing code selection, documentation sufficiency, and product reporting. Together, the testimony and evidence supported the position that the services were safe, effective, clinically appropriate, and properly billed under Medicare rules.
The Five Fully Favorable ALJ Decisions
In each of the five appeals, the ALJ entered a fully favorable decision, finding that the advanced wound-care product and related services were medically reasonable and necessary and covered under Medicare. The decisions directed the Medicare contractor to process the claims accordingly, eliminating the alleged overpayment liability at issue in the appeals. The outcomes underscore the importance of developing an evidentiary record addressing safety, effectiveness, clinical appropriateness, and other applicable Medicare coverage requirements.
These decisions are particularly significant for providers facing audits in which advanced wound-care products are frequently challenged as experimental or investigational. The contractor’s sole objection was that the product lacked product-specific, peer-reviewed evidence, such as prospective randomized controlled trials. Frier Levitt directly rebutted that assertion, arguing that no Medicare regulation requires brand-specific clinical trials, that functionally identical amniotic membrane products are supported by an extensive body of peer-reviewed literature, and that the product’s regulatory status and homologous-use principles supported coverage. By pairing policy analysis with treating-physician and coding-expert testimony, the team presented a cohesive, claim-specific case for coverage in each appeal.
What These Decisions Mean for Wound-Care Providers
For wound-care providers facing Medicare audits and overpayment demands, these results illustrate the value of a disciplined, unified defense strategy. When the record supports medical necessity, accurate coding, and compliance with Medicare coverage criteria on a claim-by-claim basis, providers may have a basis to challenge adverse audit findings through the Medicare appeals process. These five decisions also highlight the importance of developing the clinical, coding, and policy record well before an ALJ hearing.
How Frier Levitt Helps Providers Navigate Medicare Audits and Appeals
Frier Levitt’s Medicare Audits and Appeals Team represents wound-care providers nationwide in complex audits involving advanced wound care, cellular and tissue-based products, skin substitute grafts, Medicare overpayments, and coding and coverage disputes
If your practice is facing a Medicare audit or overpayment demand related to wound-care services, Frier Levitt can help evaluate the underlying records, align documentation and coding with Medicare policy, and develop an appeal strategy tailored to the claims and coverage issues at stake. Contact Frier Levitt to speak with a member of the Medicare Audits and Appeals Team.
Frequently Asked Questions About Medicare Wound-Care Audits and ALJ Appeals
Can a Medicare wound-care overpayment determination be appealed?
Yes. Providers generally have the right to challenge Medicare overpayment determinations through the Medicare administrative appeals process. Depending on the stage of the appeal, providers may present medical records, coding support, clinical evidence, expert testimony, and legal arguments addressing coverage and medical necessity.
What happens at a Medicare Administrative Law Judge hearing?
An Administrative Law Judge (ALJ) hearing provides an opportunity to present evidence and arguments concerning disputed Medicare claims. In wound-care matters, the record may include treating-physician testimony, medical records, coding analysis, product information, and evidence addressing whether the services were reasonable and necessary under applicable Medicare requirements.
What issues commonly arise in Medicare audits involving skin substitute grafts?
Medicare audits involving skin substitute grafts and other cellular and tissue-based products may focus on medical necessity, documentation, coding, product utilization, coverage requirements, and whether the treatment is considered reasonable and necessary. Because these issues are often claim-specific, the medical and billing records for each date of service can be critical to an appeal.
Why is medical documentation important in a wound-care audit?
Medical documentation helps establish why a particular treatment was clinically appropriate for the patient. Records may need to demonstrate the nature and duration of the wound, prior conservative treatment, the patient’s response to treatment, relevant comorbidities, and the clinical reasoning supporting the use of an advanced wound-care product.
Can expert testimony help in a Medicare wound-care appeal?
Expert testimony may help explain complex clinical, coding, or billing issues to an ALJ. Depending on the circumstances, testimony from the treating physician, a coding expert, or another qualified professional can help connect the underlying documentation to the applicable Medicare coverage and billing requirements.
What should a wound-care provider do after receiving a Medicare audit or overpayment demand?
Providers should carefully review the audit findings, applicable appeal deadlines, medical records, coding, and the Medicare policies cited by the contractor. Because the administrative record developed during the appeals process can affect later stages of the case, providers should consider their clinical, coding, and legal strategy early in the process.
